Heart patients get to breathe easier


KUALA LUMPUR: Heart patients often dread having a pacemaker implanted in their chests due to the size of the device and the surgery involved, but things are set to change in the next couple of years.

The National Heart Institute (IJN) has been quietly blazing the trail to come up with a cutting-edge pacemaker the size of a vitamin pill through its clinical trials.

The Micra Transcatheter Pacing System (Micra TPS), developed by medical equipment maker Medtronic, is one-tenth the size of a traditional pacemaker and does not require surgery to be implanted.

It is simply injected into the heart through a vein.

It has small tines that latch onto the heart and delivers electric impulses through an electrode at the tip, according to IJN interventional electrophysiology and implantable devices clinical director Dr Azlan Hussin.

“Unlike traditional pacemakers, the Micra TPS does not need surgical pockets under the skin, so some potential complications are eliminated along with visible signs of the device,” he said.

Patients can wear the Micra TPS and go about their daily business. The battery power is the same as that of traditional pacemakers, and will last for about eight years.

The device is designed to be left permanently in the heart.

“But if removal is deemed necessary, doctors can do it without surgery,” Dr Azlan told a press conference here yesterday.

The first-in-man trial procedure for the Micra TPS was done by IJN in 2014, and since then, over 200 patients with bradycardia (slow or irregular heart rhythm) have been fitted with the device at the hospital.

Dr Azlan also said 80 physicians from many other countries had come to IJN for training on implanting the device.

Another of IJN’s leading clinical trials involves the Attain Stability Quad lead, used by patients with weak hearts who are most prone to heart failure.

The lead resembles a thin piece of wire, which, when implanted into a vein in the heart, will protect against possibilities of sudden death due to weak heartbeats.

IJN has trained over 200 physicians across Asia-Pacific to use this lead.

But this is only the beginning, said Dr Azlan, who added that plans are afoot to develop a second-generation Micra TPS pacemaker that will last longer and has more features for patients.

“The results of our first clinical study will be presented in Boston in May, and from there we will see what to do.

“This is still under research, but all patients who have undergone the procedure to implant the Micra TPS are doing well,” he said.

Article type: metered
User Type: anonymous web
User Status:
Campaign ID: 46
Cxense type: free
User access status: 3
Join our Telegram channel to get our Evening Alerts and breaking news highlights

News , bureaus

   

Next In Nation

Focus on high-risk groups
Covid-19 booster shot advisable
Field hospital in Penang operational soon
B40 families to receive Covid-19 care packages
Extra dose not just for the elderly, but all who need it
Khairy: Half a million vaccination certificate complaints resolved
Khairy: MOH, JPA to discuss penalties for civil servants who refuse Covid-19 vaccination
Section of Penampang-Tambunan road collapses due to continuous rain
Sabah govt announces 30% capacity attendance at non-Muslim religious houses for fully vaccinated
Improving post-Covid-19 efforts should be debated at state assembly sitting, says Sabah Bersatu info chief

Stories You'll Enjoy


Vouchers